CARCINOMA, PANCREATIC DUCTAL
Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear
Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer: experimental combo trial launches
Disease control Recruiting nowThis study tests whether adding the drug relacorilant to standard chemotherapy can help people with metastatic pancreatic cancer live longer without their disease getting worse. About 60 adults who have not yet been treated for advanced pancreatic cancer will receive the combinat…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill takes on KRAS-Mutant cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new experimental drug called PF-07934040, taken as a pill, for people with advanced solid tumors that have a KRAS gene mutation. The trial includes patients with non-small cell lung cancer, colorectal cancer, and pancreatic cancer. Researchers will …
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Gene test may guide chemo choice for tough pancreatic cancer
Knowledge-focused Recruiting nowThis pilot study aims to see if using five gene signatures from a patient's tumor can help doctors choose the best first chemotherapy for advanced pancreatic cancer. About 85 people with metastatic pancreatic cancer will have their tumor genes analyzed to pick between two standar…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC